Medical research

Study confirms how RNA chemical modifications benefit HIV-1

A chemical modification in the HIV-1 RNA genome whose function has been a matter of scientific debate is now confirmed to be key to the virus's ability to survive and thrive after infecting host cells, a new study has found.

Diseases, Conditions, Syndromes

Using machine learning to track the evolution of COVID-19

Scientists have developed a machine-learning approach to track the evolution of SARS‑CoV‑2, the virus that causes COVID-19, and potentially other viruses, according to a study published in the Proceedings of the National ...

Diseases, Conditions, Syndromes

Mathematicians use AI to identify emerging COVID-19 variants

Scientists at The Universities of Manchester and Oxford have developed an AI framework that can identify and track new and concerning COVID-19 variants and could help with other infections in the future.

HIV & AIDS

Scientists see an ultra-fast movement on surface of HIV virus

As the HIV virus glides up outside a human cell to dock and possibly inject its deadly cargo of genetic code, there's a spectacularly brief moment in which a tiny piece of its surface snaps open to begin the process of infection.

Diseases, Conditions, Syndromes

Portable laboratory device can detect SARS-CoV-2

A new study has demonstrated rapid and sensitive on-site detection of SARS-CoV-2 RNA from environmental surfaces using a portable laboratory device. The study was published in Microbiology Spectrum.

Genetics

SARS-CoV-2: The grasping fingers of the viral N protein

Immediately after the infection of a cell in the throat or lungs, the SARS-CoV-2 virus works very hard to replicate, using the human cell's metabolic pathways to produce its proteins and make sure that its genetic material ...

Medications

Universal siRNA COVID-19 treatment shows promise in the lab

Lab data in cells has shown that siRNA has the potential to treat COVID-19 infection better than existing antivirals, according to new research from UNSW's Kirby and RNA Institutes, published today in Antiviral Research.

page 2 from 30